NetworkNewsBreaks – Trxade Group Inc. (NASDAQ: M
Post# of 174

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, recently had the opportunity to showcase its growing medical technology accomplishments at multiple virtual investor conferences. Trxade Group CEO Suren Ajjarapu took the company’s message well beyond physical borders to virtual summits in the month of September, providing insight into the dynamic capabilities and expansion of the Trxade Exchange platform. A recent article discussing this reads, “Trxade Group has been building its B2B platform into a B2C-friendly portfolio that helps independent local pharmacies compete with large-scale retail chains through drug pricing transparency and network strength. The platform also assists health patients to gain telemedicine access to physicians’ clinics without leaving home, and to have prescriptions ordered online and delivered to the home (http://nnw.fm/OW3fh).
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

